Ready to Help Whenever You Need Us

We know who to talk to, where to find answers, and what steps you need to take. Let us put our 30 years of experience to work for you.

Possible Link between Singulair and Suicidal Behavior

Singulair is a medicine in the drug class known as leukotriene receptor antagonists. Singulair is used to treat asthma and allergy symptoms, such as sneezing, stuffy nose, runny nose, and itching of the nose. It is also used to prevent exercise induced asthma.

The Food and Drug Administration (FDA) is working with Singulair’s maker, Merck & Co., Inc., to further evaluate the possible link between the use of Singulair and behavior/mood changes, suicidality and suicide. The FDA expects that it may take up to 9 months to complete the ongoing evaluations. In addition, the agency is reviewing post-marketing reports of similar behavior in patients taking other leukotriene-modifying medications, including zafirlukast (Accolate) and zileuton (Zyflo and Zyflo CR).

If you or your loved one has suffered a Singulair injury, contact us today. Submit the form to the right and we’ll let you know if you have a case and if we can represent you.